The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-1-methyl-5-phenyl-6-((1-phenylethyl)thio)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one ID: ALA4876602
PubChem CID: 132259554
Max Phase: Preclinical
Molecular Formula: C20H18N4OS
Molecular Weight: 362.46
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: C[C@@H](Sc1nc2c(cnn2C)c(=O)n1-c1ccccc1)c1ccccc1
Standard InChI: InChI=1S/C20H18N4OS/c1-14(15-9-5-3-6-10-15)26-20-22-18-17(13-21-23(18)2)19(25)24(20)16-11-7-4-8-12-16/h3-14H,1-2H3/t14-/m1/s1
Standard InChI Key: JNPNRKXZLIGUCT-CQSZACIVSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
3.5975 -19.4805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5964 -20.3000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3044 -20.7090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0141 -20.2995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0113 -19.4769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3026 -19.0716 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8849 -20.7104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1742 -20.2966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1787 -21.9393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.8867 -21.5272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1756 -19.4779 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4625 -21.5285 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4633 -20.7042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6796 -20.4487 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1944 -21.1152 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.6783 -21.7824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4251 -22.5594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5945 -21.9353 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.5950 -22.7525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3029 -23.1607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2983 -23.9761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0054 -24.3842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7139 -23.9752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7108 -23.1538 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0031 -22.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8875 -23.1615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
7 8 1 0
8 13 1 0
12 9 1 0
9 10 2 0
10 7 1 0
8 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 12 1 0
16 17 1 0
10 18 1 0
19 18 1 1
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
19 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 362.46Molecular Weight (Monoisotopic): 362.1201AlogP: 3.97#Rotatable Bonds: 4Polar Surface Area: 52.71Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 4.48CX LogD: 4.48Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.41Np Likeness Score: -1.96
References 1. Huddle BC, Grimley E, Chtcherbinine M, Buchman CD, Takahashi C, Debnath B, McGonigal SC, Mao S, Li S, Felton J, Pan S, Wen B, Sun D, Neamati N, Buckanovich RJ, Hurley TD, Larsen SD.. (2021) Development of 2,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one inhibitors of aldehyde dehydrogenase 1A (ALDH1A) as potential adjuncts to ovarian cancer chemotherapy., 211 [PMID:33341649 ] [10.1016/j.ejmech.2020.113060 ]